Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) EBT (2016 - 2026)

Skinvisible's EBT history spans 16 years, with the latest figure at -$258357.0 for Q4 2025.

  • On a quarterly basis, EBT rose 29.68% to -$258357.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1 million, a 15.13% increase, with the full-year FY2025 number at -$1.1 million, up 15.13% from a year prior.
  • EBT hit -$258357.0 in Q4 2025 for Skinvisible, down from -$250245.0 in the prior quarter.
  • Over the last five years, EBT for SKVI hit a ceiling of -$148564.0 in Q2 2021 and a floor of -$1.5 million in Q1 2023.
  • Historically, EBT has averaged -$365751.4 across 5 years, with a median of -$291159.0 in 2024.
  • Biggest five-year swings in EBT: crashed 309.64% in 2023 and later soared 80.85% in 2024.
  • Tracing SKVI's EBT over 5 years: stood at -$461660.0 in 2021, then grew by 11.43% to -$408893.0 in 2022, then grew by 25.58% to -$304295.0 in 2023, then decreased by 20.74% to -$367406.0 in 2024, then grew by 29.68% to -$258357.0 in 2025.
  • Business Quant data shows EBT for SKVI at -$258357.0 in Q4 2025, -$250245.0 in Q3 2025, and -$278957.0 in Q2 2025.